noom vs hers glp 1 Noom: Approach, Pricing, Compounded Pathway I wanted to share this

Drawing from PSGs 2025 Trends in Drug Benefit Design Report, this webinar provides essential insights for benefits professionals navigating the complex landscape of GLP-1 coverage decisions

[DOI] [PubMed] [Google Scholar] 7.Karuga F.F., Jaromirska J., Sochal M., Biaasiewicz P., Gabryelska A

Because medications like Wegovy interact directly with these receptors to control appetite, they may also inadvertently influence the temperature-regulating signals in the brain

This allows for deeper study of pathway-specific activity without the confounding effects of poly-compound blends

Losing weight had so many positive effects on my life, but it also forced me to revisit some painful memories and emotions